Souhaitez-vous accéder aux communiqués récents ?

Cenrifki de Sanofi (tolebrutinib) recommandé par le Comité des médicaments à usage humain (CMUH) pour être approuvé par l’UE pour le traitement de la sclérose en plaques secondairement progressive...

Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses Recommendation based on the HERCULES phase 3 study which...

EXECUTIVE SUMMARY final European scientific advice received for pivotal Phase III vitiligo studyEMA emphasised its “totality of evidence” approachcentral photographic review and validated disease...

Austin, TX, USA, April 23, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Water and Wastewater Treatment Market Size, Trends and Insights By Treatment...

PridCor secures global antiviral portfolio with Phase 2b and Phase 3 assets to advance treatments for Long COVID and chronic illness.

Richmond, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Lotus Foods, a global pioneer in heirloom, organic, and regenerative rice cultivation, today released its 2025 Impact Report, highlighting...

PLANTATION, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (Nasdaq: AENT), a premier distributor and omnichannel fulfillment partner to the entertainment and pop...

Expands Nanox’s growing network of U.S. distribution partnerships PETAH TIKVA, Israel, April 23, 2026 (GLOBE NEWSWIRE) -- Nano-X Imaging Ltd. (“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in...

Former CEO criticizes TransAct’s strategy shift to software, citing lost momentum, stock decline, and urges refocus on core hardware strengths.

LUXEMBOURG, April 23, 2026 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage...